Bank of New York Mellon Corp cut its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 11.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 297,864 shares of the technology company’s stock after selling 37,464 shares during the quarter. Bank of New York Mellon Corp’s holdings in Amdocs were worth $27,177,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. Quarry LP grew its holdings in Amdocs by 42.2% during the first quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after buying an additional 116 shares in the last quarter. Alhambra Investment Management LLC lifted its stake in Amdocs by 5.0% during the 2nd quarter. Alhambra Investment Management LLC now owns 2,585 shares of the technology company’s stock valued at $236,000 after acquiring an additional 124 shares in the last quarter. William Blair Investment Management LLC boosted its holdings in Amdocs by 2.4% during the 2nd quarter. William Blair Investment Management LLC now owns 5,650 shares of the technology company’s stock worth $516,000 after acquiring an additional 133 shares during the last quarter. Mutual Advisors LLC grew its stake in shares of Amdocs by 3.2% in the 2nd quarter. Mutual Advisors LLC now owns 4,516 shares of the technology company’s stock worth $397,000 after acquiring an additional 138 shares in the last quarter. Finally, MGO One Seven LLC grew its stake in shares of Amdocs by 5.1% in the 2nd quarter. MGO One Seven LLC now owns 2,899 shares of the technology company’s stock worth $264,000 after acquiring an additional 140 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on DOX. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Bank of America cut their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Stifel Nicolaus decreased their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.00.
Amdocs Stock Up 1.1%
Amdocs stock opened at $77.74 on Friday. The firm has a 50 day moving average price of $83.02 and a 200-day moving average price of $87.27. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a twelve month low of $75.35 and a twelve month high of $95.41. The company has a market capitalization of $8.78 billion, a P/E ratio of 15.77, a P/E/G ratio of 1.40 and a beta of 0.51.
Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the previous year, the firm posted $1.70 EPS. Amdocs’s revenue was down 9.0% on a year-over-year basis. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. As a group, equities analysts predict that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Wednesday, December 31st. Amdocs’s dividend payout ratio is currently 41.58%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Are These 3 Oversold Tech Giants Ready to Rebound?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- Election Stocks: How Elections Affect the Stock Market
- 3 Stocks Quietly Powering the AI and Tech Revolution
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
